This product is available in both preservative-free and preserved formulations, each supplied in a 30 mL vial at a concentration of 500 mg/mL
The outcomes were described using forest plots
Personalized multimorbidity management for patients with type 2 diabetes using reinforcement learning of electronic health records
Histological evaluation of major organs and blood tests reveal no signs of systemic toxicity or inflammatory pathology, supporting a favorable safety profile
Some state Medicaid programs may cover tirzepatide for eligible individuals with type 2 diabetes or weight loss, while others might not include it on their formulary
You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE /CHAMPUS, or any state prescription drug assistance program